Both in Pharmaceuticals
Xeris Biopharma Holdings vs Zenas BioPharma
Over the past year XERS returned +10.4% and ZBIO returned −9.2%; their daily moves had a correlation of 0.11.
XERS +10.4% ZBIO −9.2%Growth of $1, one year, split-adjusted
| Metric | XERS | ZBIO |
|---|---|---|
| Price | $10.71 | $28.39 |
| Market cap | $1.95B | $1.85B |
| Today | −0.37% | −1.29% |
| 1 month | +15.8% | +1.6% |
| 6 months | +70.5% | +46.6% |
| Year to date | +36.4% | −21.8% |
| 1 year | +11.3% | +1.4% |
| Revenue growth (YoY) | +28.7% | — |
| Gross margin | 86.4% | 100.0% |
| Net margin | −33.8% | −11145.6% |
| P/E (TTM) | — | — |
| Price / sales | 5.8× | 1,850.4× |
| Net cash | -$130.8M | $346.1M |
| Dividend yield | — | — |
| Volatility (60d) | 53.0% | 55.5% |
| Short % of float | 4.6% | 40.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).